Rapid Micro BIOSYSTEMS, Inc. (RPID) intrinsic value & 10-year financials
Rapid Micro BIOSYSTEMS, Inc. (RPID) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 15.9% a year to $33.6M, with an average return on invested capital of -23.6%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.76
- Market cap
- $34.1M
- Revenue (FY2025)
- $33.6M
- Revenue growth (7-yr CAGR)
- 15.9%
- ROIC (10-yr avg)
- -23.6%
- Free cash flow (FY2025)
- -$31.9M
RPID 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $33.6M | -$47.1M | -$1.05 | -$31.9M | -141.1% | -95.6% |
| FY2024 | $28.1M | -$46.9M | -$1.08 | -$45.5M | -178.0% | -61.1% |
| FY2023 | $22.5M | -$52.5M | -$1.22 | -$46.9M | -251.2% | -46.3% |
| FY2022 | $17.1M | -$60.8M | -$1.43 | -$65.3M | -369.0% | -67.0% |
| FY2021 | $23.2M | -$73.5M | -$3.94 | -$58.2M | -203.3% | 105.3% |
| FY2020 | $16.1M | -$37.1M | -$2.29 | -$31.7M | -190.0% | 23.1% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
RAPID MICRO BIOSYSTEMS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
RAPID MICRO BIOSYSTEMS, INC. has historically struggled to out-earn its cost of capital, averaging just -23.6% ROIC.
RAPID MICRO BIOSYSTEMS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, RAPID MICRO BIOSYSTEMS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-34.88 per share.